Latanelb

Latanoprost, the active ingredient in Latanelb, is a prostaglandin analog presented as an ophthalmic solution for ocular use. It lowers intraocular pressure and is used to treat open‑angle glaucoma and ocular hypertension in adult patients. GNH USA supplies Latanelb as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Latanoprost is a prostaglandin analog that reduces intraocular pressure in glaucoma‑related conditions.

Open‑angle glaucoma: lowers intraocular pressure and helps prevent optic nerve damage. Ocular hypertension: reduces eye pressure to lower the risk of developing glaucoma. Pseudoexfoliative glaucoma: decreases intraocular pressure in this secondary form of glaucoma.

Latanoprost may cause ocular and systemic reactions, most of which are mild and reversible.

Common Side Effects: - Eye redness: mild conjunctival hyperemia. - Increased eyelash growth: longer, thicker lashes. - Iris pigmentation: gradual darkening of the iris. - Eye irritation: burning or stinging sensation. - Blurred vision: transient visual disturbance. - Foreign body sensation: feeling of something in the eye.

Serious or Rare Side Effects: - Severe allergic reaction: swelling, rash, or difficulty breathing. - Uveitis: inflammation of the uveal tract. - Corneal edema: swelling of the cornea affecting vision. - Paradoxical IOP increase: unexpected rise in intraocular pressure. - Endophthalmitis: intraocular infection requiring urgent care. - Persistent ocular pain: continuous discomfort beyond initial period.

Before using Latanelb, consider the following safety measures.

Pregnancy: Category C; use only if the potential benefit justifies the potential risk to the fetus. Breastfeeding: Caution advised; limited data on excretion in breast milk. Hypersensitivity: Contraindicated in patients with known allergy to latanoprost or any excipient. Regular monitoring: Schedule periodic intraocular pressure checks to assess efficacy. Contact lens wear: Remove lenses before instillation and wait before reinserting. Store at room temperature: keep in the original container, protect from light and moisture.

Latanoprost may interact with other ocular or systemic agents.

Major Interactions (Avoid): - Concurrent prostaglandin analogs: may increase risk of ocular side effects. - Systemic carbonic anhydrase inhibitors: additive intraocular pressure reduction; monitor closely. - Ocular anesthetics: may diminish latanoprost efficacy.

Moderate Interactions (Monitor Closely): - Beta‑blocker eye drops: potential additive IOP‑lowering effect. - Systemic beta‑blockers: possible systemic absorption leading to cardiovascular effects. - Other ocular hypotensive agents: may require dose adjustment to avoid excessive pressure drop.